(Q40049460)

16 September 2017

title

Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate (English)

1 reference

16 September 2017

1 reference

1 reference

Jesús A Junco

1

1 reference

16 September 2017

Peter Peschke

2

1 reference

16 September 2017

Ivan Zuna

3

1 reference

16 September 2017

Volker Ehemann

4

1 reference

16 September 2017

Franklin Fuentes

5

1 reference

16 September 2017

Eddy Bover

6

1 reference

16 September 2017

Eulogio Pimentel

7

1 reference

16 September 2017

Roberto Basulto

8

1 reference

16 September 2017

Osvaldo Reyes

9

1 reference

16 September 2017

Lesvia Calzada

10

1 reference

16 September 2017

María D Castro

11

1 reference

16 September 2017

Niurka Arteaga

12

1 reference

16 September 2017

Yovisleidis López

13

1 reference

16 September 2017

Hilda Garay

14

1 reference

16 September 2017

Héctor Hernández

15

1 reference

16 September 2017

Ricardo Bringas

16

1 reference

16 September 2017

Gerardo E Guillén

17

1 reference

16 September 2017

language of work or name

English

0 references

publication date

4 October 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

25

1 reference

16 September 2017

issue

50

1 reference

16 September 2017

page(s)

8460-8468

1 reference

Treatment of prostate cancer with gonadotropin-releasing hormone agonists

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Ability of an anti-luteinizing hormone-releasing hormone vaccine to inhibit gonadotropins in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Effective synthetic peptide vaccine for foot-and-mouth disease in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Immunotherapy of non-metastatic complication of malignant disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Semisynthetic anti-LHRH vaccine causing atrophy of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Effect of active immunization to luteinizing-hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Highly immunogenic and fully synthetic peptide-carrier constructs targetting GnRH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Immunocontraception of white-tailed deer with GnRH vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Efficient immunocastration of male piglets by immunoneutralization of GnRH using a new GnRH-like peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Vaccines for control of fertility and hormone-dependent cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Monoclonal antibodies against LHRH: development and immunoactivity in vivo and in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Bypass by an alternate ‘carrier’ of acquired unresponsiveness to hCG upon repeated immunization with tetanus-conjugated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Effects of long-term immunization against LHRH and androgen treatment on gonadal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Use of Prior Vaccinations for the Development of New Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

Direct inhibitory actions of GnRH on accessory reproductive organs of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.033

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.09.033

1 reference

16 September 2017

1 reference